Skip to content
Screener

Neuronetics STIM Free cash flow

Free cash flow at other companies

LBR
LB Pharmaceuticals IncLBRX
-$23.32M-186%
LifeStance Health Group logo
LifeStance Health GroupLFST
$87.92M+55.2%
Neuropace, Inc. logo
Neuropace, Inc.NPCE
-$4.03M-78.7%
ClearPoint Neuro logo
ClearPoint NeuroCLPT
-$8.61M-35.5%
Orthofix Medical Inc. logo
Orthofix Medical Inc.OFIX
-$18.87M
Stereotaxis logo
StereotaxisSTXS
-$3.74M

Other financials

Income statement

See full
Revenue$41.6M+9.1%
Gross profit$21.2M+19.5%
Operating income-$1.5M+81.4%
Net income-$3.4M+66.0%
EPS (diluted)-$0.05+66.7%

Balance sheet

See full
Cash & equivalents$19.2M+75.0%
Total debt$86.5M+7.3%
Total equity$17.9M-34.2%
Total assets$131.5M-2.3%

Cash flow

See full
Operating cash flow-$1.0M+71.2%
CapEx$417.0K+65.5%

Valuation

See full
Market cap$210.3M+11.6%
Enterprise value$277.63M+7.5%
P/S1.4×-0.3×

Profitability

See full
Gross margin49.1%-7.0pp
Operating margin-14.7%-5.4pp
Net margin-19.6%-7.0pp
FCF margin-7.7%-3.3pp

Returns & leverage

See full
Return on equity-135.3%-35.4pp
Debt / equity4.8×+1.9×
Current ratio1.9×-0.1×

Where this comes from

Calculated from Neuronetics’s reported figures.

The source filing: Neuronetics’s 10-Q, filed August 11, 2026. Open the filing →

Filed
Aug 11, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-094078

FAQ

What is Neuronetics's free cash flow?
Neuronetics (STIM) reported free cash flow of -$1.43M in Q2 2026.
How has Neuronetics's free cash flow changed year-over-year?
Neuronetics's free cash flow increased by 62.1% year-over-year, from -$3.76M to -$1.43M.
What is the long-term trend for Neuronetics's free cash flow?
Over 4 years (2021 to 2025), Neuronetics's free cash flow has grown at a -7.9% compound annual growth rate (CAGR), from -$30.34M to -$21.87M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.

Ask your AI about Neuronetics's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude